| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Elephants | 20 | 2022 | 41 | 9.530 |
Why?
|
| Herpesviridae Infections | 22 | 2024 | 142 | 9.210 |
Why?
|
| Herpesviridae | 17 | 2023 | 31 | 7.390 |
Why?
|
| Viral Proteins | 18 | 2020 | 347 | 3.100 |
Why?
|
| Herpesvirus 4, Human | 26 | 2019 | 659 | 3.020 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 22 | 2019 | 60 | 2.800 |
Why?
|
| Animals, Zoo | 7 | 2021 | 15 | 1.530 |
Why?
|
| Epstein-Barr Virus Infections | 8 | 2015 | 285 | 1.430 |
Why?
|
| Cell Transformation, Viral | 7 | 2019 | 106 | 1.260 |
Why?
|
| B-Lymphocytes | 12 | 2019 | 517 | 1.240 |
Why?
|
| Nuclear Proteins | 10 | 2013 | 1265 | 1.220 |
Why?
|
| Viremia | 6 | 2022 | 126 | 1.220 |
Why?
|
| DNA, Viral | 11 | 2016 | 477 | 1.220 |
Why?
|
| Vaccines, Subunit | 2 | 2024 | 66 | 1.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 5 | 2016 | 511 | 1.090 |
Why?
|
| Immunity, Cellular | 2 | 2024 | 203 | 1.070 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2013 | 467 | 1.060 |
Why?
|
| Transcriptional Activation | 10 | 2015 | 481 | 1.020 |
Why?
|
| Gene Expression Regulation, Viral | 10 | 2019 | 132 | 0.980 |
Why?
|
| Viral Matrix Proteins | 7 | 2011 | 109 | 0.980 |
Why?
|
| Immunity, Humoral | 1 | 2024 | 69 | 0.900 |
Why?
|
| Rhadinovirus | 2 | 2013 | 4 | 0.890 |
Why?
|
| Vaccinia | 1 | 2022 | 8 | 0.800 |
Why?
|
| Animals | 32 | 2024 | 33714 | 0.790 |
Why?
|
| Herpesvirus 3, Equid | 1 | 2021 | 3 | 0.780 |
Why?
|
| Hemorrhagic Disorders | 1 | 2021 | 17 | 0.780 |
Why?
|
| Transcription Factors | 5 | 2013 | 2584 | 0.740 |
Why?
|
| Cell Nucleus | 6 | 2009 | 673 | 0.700 |
Why?
|
| Animal Diseases | 1 | 2020 | 6 | 0.690 |
Why?
|
| Virus Latency | 7 | 2019 | 61 | 0.670 |
Why?
|
| Betaherpesvirinae | 2 | 2020 | 5 | 0.670 |
Why?
|
| Antibodies, Viral | 6 | 2024 | 1135 | 0.660 |
Why?
|
| Molecular Sequence Data | 20 | 2015 | 3868 | 0.660 |
Why?
|
| Antigens, Nuclear | 3 | 2011 | 61 | 0.650 |
Why?
|
| Autoantigens | 3 | 2011 | 119 | 0.630 |
Why?
|
| Viral Load | 3 | 2013 | 382 | 0.600 |
Why?
|
| Antigens, Viral | 7 | 2020 | 436 | 0.580 |
Why?
|
| Trans-Activators | 3 | 2015 | 809 | 0.560 |
Why?
|
| Base Sequence | 15 | 2016 | 3091 | 0.520 |
Why?
|
| Virus Replication | 4 | 2013 | 603 | 0.500 |
Why?
|
| Endangered Species | 1 | 2015 | 9 | 0.490 |
Why?
|
| Promoter Regions, Genetic | 10 | 2005 | 1336 | 0.490 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2015 | 43 | 0.490 |
Why?
|
| Mutant Proteins | 1 | 2015 | 112 | 0.480 |
Why?
|
| Rodent Diseases | 1 | 2013 | 17 | 0.460 |
Why?
|
| Ribonucleotide Reductases | 1 | 2013 | 10 | 0.450 |
Why?
|
| Host-Pathogen Interactions | 2 | 2013 | 251 | 0.440 |
Why?
|
| Peritoneum | 1 | 2013 | 36 | 0.440 |
Why?
|
| Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor | 1 | 2013 | 3 | 0.430 |
Why?
|
| Varicellovirus | 1 | 2013 | 1 | 0.430 |
Why?
|
| Mouth Diseases | 1 | 2013 | 11 | 0.430 |
Why?
|
| Cell Line | 10 | 2013 | 2772 | 0.420 |
Why?
|
| DNA-Binding Proteins | 11 | 2004 | 2047 | 0.420 |
Why?
|
| Sumoylation | 1 | 2013 | 33 | 0.420 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2013 | 33 | 0.420 |
Why?
|
| Gammaherpesvirinae | 2 | 2013 | 5 | 0.420 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2013 | 80 | 0.410 |
Why?
|
| Veterinary Medicine | 1 | 2012 | 8 | 0.410 |
Why?
|
| Herpesvirus Vaccines | 2 | 2024 | 3 | 0.410 |
Why?
|
| 2-Aminopurine | 3 | 2017 | 4 | 0.410 |
Why?
|
| Virology | 1 | 2012 | 31 | 0.410 |
Why?
|
| Amino Acid Sequence | 12 | 2015 | 2697 | 0.390 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2011 | 57 | 0.380 |
Why?
|
| Nasal Mucosa | 1 | 2011 | 65 | 0.380 |
Why?
|
| Fibroblasts | 2 | 2013 | 878 | 0.370 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 452 | 0.370 |
Why?
|
| Lymphoma, T-Cell | 1 | 2011 | 64 | 0.370 |
Why?
|
| Genotype | 3 | 2013 | 2539 | 0.370 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 354 | 0.370 |
Why?
|
| Serologic Tests | 2 | 2021 | 117 | 0.350 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 353 | 0.350 |
Why?
|
| Transcription, Genetic | 5 | 2005 | 1695 | 0.350 |
Why?
|
| Mice | 8 | 2024 | 17486 | 0.340 |
Why?
|
| Promyelocytic Leukemia Protein | 3 | 2013 | 12 | 0.330 |
Why?
|
| Killer Cells, Natural | 1 | 2011 | 319 | 0.330 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1676 | 0.330 |
Why?
|
| Virus Shedding | 2 | 2013 | 79 | 0.320 |
Why?
|
| Cytoplasm | 1 | 2009 | 289 | 0.300 |
Why?
|
| Interferons | 1 | 2008 | 123 | 0.300 |
Why?
|
| Polymerase Chain Reaction | 5 | 2023 | 1584 | 0.280 |
Why?
|
| RNA, Messenger | 7 | 2015 | 2814 | 0.280 |
Why?
|
| Cytomegalovirus | 2 | 2011 | 268 | 0.280 |
Why?
|
| Antiviral Agents | 3 | 2017 | 744 | 0.280 |
Why?
|
| Blotting, Western | 3 | 2015 | 1101 | 0.280 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 752 | 0.270 |
Why?
|
| MicroRNAs | 2 | 2019 | 826 | 0.260 |
Why?
|
| DNA Primers | 4 | 2015 | 660 | 0.250 |
Why?
|
| Viral Envelope Proteins | 2 | 2024 | 150 | 0.250 |
Why?
|
| Herpesvirus 1, Equid | 1 | 2024 | 2 | 0.240 |
Why?
|
| Saliva | 3 | 2017 | 113 | 0.240 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2003 | 265 | 0.230 |
Why?
|
| Female | 14 | 2024 | 65494 | 0.220 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 287 | 0.220 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2015 | 657 | 0.220 |
Why?
|
| Lymphocytes | 1 | 2005 | 401 | 0.220 |
Why?
|
| JC Virus | 1 | 2003 | 28 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 812 | 0.210 |
Why?
|
| Sequence Alignment | 5 | 2010 | 623 | 0.210 |
Why?
|
| Molecular Epidemiology | 1 | 2003 | 156 | 0.210 |
Why?
|
| BK Virus | 1 | 2003 | 59 | 0.210 |
Why?
|
| Virus Activation | 1 | 2003 | 86 | 0.210 |
Why?
|
| Proteolysis | 2 | 2013 | 165 | 0.200 |
Why?
|
| Male | 13 | 2021 | 60083 | 0.200 |
Why?
|
| Immunoglobulin G | 2 | 2015 | 770 | 0.200 |
Why?
|
| Mice, Inbred BALB C | 1 | 2024 | 1001 | 0.200 |
Why?
|
| HIV-1 | 2 | 2003 | 465 | 0.200 |
Why?
|
| Sequence Analysis, DNA | 4 | 2016 | 1758 | 0.190 |
Why?
|
| HIV Infections | 3 | 2004 | 1866 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1291 | 0.190 |
Why?
|
| Sensitivity and Specificity | 3 | 2016 | 2025 | 0.190 |
Why?
|
| Genome, Viral | 2 | 2013 | 171 | 0.190 |
Why?
|
| HeLa Cells | 3 | 2015 | 809 | 0.190 |
Why?
|
| Immunity | 1 | 2022 | 182 | 0.180 |
Why?
|
| Peptides | 2 | 2002 | 794 | 0.180 |
Why?
|
| Immunoprecipitation | 2 | 2015 | 198 | 0.180 |
Why?
|
| Glycoproteins | 1 | 2022 | 369 | 0.170 |
Why?
|
| Specimen Handling | 1 | 2020 | 141 | 0.170 |
Why?
|
| Protein Interaction Mapping | 2 | 2013 | 85 | 0.170 |
Why?
|
| Sequence Homology, Nucleic Acid | 5 | 2010 | 287 | 0.160 |
Why?
|
| Receptors, Cell Surface | 1 | 2001 | 469 | 0.160 |
Why?
|
| Open Reading Frames | 2 | 2010 | 211 | 0.160 |
Why?
|
| Cell Proliferation | 2 | 2019 | 2306 | 0.160 |
Why?
|
| Carrier Proteins | 1 | 2004 | 1019 | 0.160 |
Why?
|
| Humans | 25 | 2019 | 123184 | 0.150 |
Why?
|
| Cloning, Molecular | 5 | 2015 | 892 | 0.150 |
Why?
|
| Asia | 1 | 2018 | 107 | 0.150 |
Why?
|
| Protein Transport | 2 | 2009 | 369 | 0.150 |
Why?
|
| RNA, Viral | 3 | 2011 | 541 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2015 | 462 | 0.140 |
Why?
|
| In Situ Hybridization | 2 | 2023 | 473 | 0.140 |
Why?
|
| Papio | 4 | 2000 | 59 | 0.140 |
Why?
|
| Binding Sites | 6 | 2004 | 1291 | 0.140 |
Why?
|
| Protein Binding | 3 | 2009 | 1741 | 0.130 |
Why?
|
| Receptors, IgE | 2 | 1994 | 10 | 0.130 |
Why?
|
| Lymphocryptovirus | 3 | 2000 | 3 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2019 | 3046 | 0.120 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2015 | 43 | 0.120 |
Why?
|
| Chromatography, Gel | 1 | 2015 | 96 | 0.120 |
Why?
|
| Sequence Deletion | 2 | 2008 | 527 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 262 | 0.120 |
Why?
|
| Protein Multimerization | 1 | 2015 | 122 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2015 | 313 | 0.120 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1994 | 55 | 0.120 |
Why?
|
| Immunoglobulin A | 1 | 2015 | 197 | 0.120 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 357 | 0.110 |
Why?
|
| Immunoglobulin M | 1 | 2015 | 210 | 0.110 |
Why?
|
| Animals, Wild | 1 | 2014 | 24 | 0.110 |
Why?
|
| Fungal Proteins | 1 | 1994 | 134 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2001 | 1530 | 0.110 |
Why?
|
| Acute-Phase Proteins | 1 | 2013 | 46 | 0.110 |
Why?
|
| India | 1 | 2014 | 217 | 0.110 |
Why?
|
| Gene Expression | 2 | 2011 | 1565 | 0.110 |
Why?
|
| Rabies Vaccines | 1 | 2013 | 10 | 0.110 |
Why?
|
| Protein Conformation | 1 | 2015 | 835 | 0.110 |
Why?
|
| Tetanus Toxoid | 1 | 2013 | 45 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 2 | 1999 | 297 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 227 | 0.110 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2003 | 229 | 0.100 |
Why?
|
| Genes, Viral | 2 | 2010 | 183 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 2528 | 0.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1994 | 274 | 0.100 |
Why?
|
| Immunization | 1 | 2013 | 308 | 0.090 |
Why?
|
| Immediate-Early Proteins | 1 | 2011 | 58 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2013 | 803 | 0.090 |
Why?
|
| Antibodies, Bacterial | 1 | 2013 | 382 | 0.090 |
Why?
|
| Phylogeny | 1 | 2013 | 689 | 0.090 |
Why?
|
| Transfection | 2 | 2004 | 1067 | 0.090 |
Why?
|
| Pregnancy | 2 | 2013 | 7146 | 0.090 |
Why?
|
| Lymphocyte Activation | 2 | 2002 | 676 | 0.080 |
Why?
|
| Gene Amplification | 1 | 2010 | 228 | 0.080 |
Why?
|
| DNA | 2 | 2000 | 1592 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2013 | 991 | 0.080 |
Why?
|
| Plasmids | 1 | 2010 | 510 | 0.080 |
Why?
|
| Estrogens | 2 | 2002 | 507 | 0.080 |
Why?
|
| Carcinoma | 1 | 2011 | 278 | 0.080 |
Why?
|
| Reference Values | 1 | 2010 | 696 | 0.080 |
Why?
|
| Structure-Activity Relationship | 3 | 1995 | 568 | 0.080 |
Why?
|
| Time Factors | 2 | 2013 | 6211 | 0.080 |
Why?
|
| Conserved Sequence | 3 | 2000 | 293 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 114 | 0.080 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 3 | 2004 | 14 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 1012 | 0.080 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 92 | 0.080 |
Why?
|
| Texas | 1 | 2016 | 3560 | 0.070 |
Why?
|
| Adult | 5 | 2015 | 29065 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 2847 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2008 | 262 | 0.070 |
Why?
|
| Repressor Proteins | 2 | 2009 | 810 | 0.070 |
Why?
|
| Mutation | 2 | 2015 | 5771 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2000 | 312 | 0.060 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2010 | 463 | 0.060 |
Why?
|
| Receptors, Complement 3d | 1 | 2005 | 5 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2013 | 3714 | 0.060 |
Why?
|
| Cell Line, Transformed | 2 | 2002 | 170 | 0.060 |
Why?
|
| Transcription Factor HES-1 | 1 | 2005 | 16 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 66 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 617 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 1385 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1681 | 0.060 |
Why?
|
| Leukoplakia, Hairy | 1 | 2004 | 1 | 0.060 |
Why?
|
| Acyclovir | 1 | 2004 | 45 | 0.060 |
Why?
|
| Mouth Mucosa | 1 | 2004 | 50 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1995 | 317 | 0.060 |
Why?
|
| LIM Domain Proteins | 1 | 2004 | 59 | 0.060 |
Why?
|
| Valine | 1 | 2004 | 105 | 0.060 |
Why?
|
| Biomarkers, Tumor | 1 | 2011 | 1429 | 0.060 |
Why?
|
| Genes, myc | 1 | 2004 | 98 | 0.060 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2005 | 214 | 0.060 |
Why?
|
| Alleles | 1 | 2008 | 1603 | 0.050 |
Why?
|
| Urine | 1 | 2003 | 88 | 0.050 |
Why?
|
| In Vitro Techniques | 2 | 1995 | 966 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2005 | 864 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 269 | 0.050 |
Why?
|
| Burkitt Lymphoma | 1 | 2004 | 145 | 0.050 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2023 | 80 | 0.050 |
Why?
|
| Genetic Complementation Test | 1 | 2002 | 86 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2005 | 382 | 0.050 |
Why?
|
| CD4 Antigens | 1 | 2002 | 55 | 0.050 |
Why?
|
| HIV Antibodies | 1 | 2002 | 69 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2005 | 543 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 325 | 0.050 |
Why?
|
| Culture Media | 1 | 2002 | 182 | 0.050 |
Why?
|
| Seasons | 1 | 2003 | 303 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2002 | 125 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 554 | 0.050 |
Why?
|
| Receptor, Notch1 | 1 | 2001 | 66 | 0.050 |
Why?
|
| Nuclear Localization Signals | 1 | 2000 | 15 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2002 | 262 | 0.050 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein D | 1 | 2000 | 4 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 531 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2002 | 193 | 0.040 |
Why?
|
| Ireland | 1 | 2020 | 27 | 0.040 |
Why?
|
| Food Microbiology | 1 | 2020 | 25 | 0.040 |
Why?
|
| Blood Specimen Collection | 1 | 2020 | 46 | 0.040 |
Why?
|
| Animal Feed | 1 | 2020 | 77 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 160 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2000 | 247 | 0.040 |
Why?
|
| Cell Division | 1 | 2001 | 779 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2005 | 518 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2003 | 1311 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2002 | 793 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2002 | 501 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 1062 | 0.040 |
Why?
|
| Apoptosis | 1 | 2004 | 1781 | 0.040 |
Why?
|
| Molecular Weight | 1 | 1998 | 392 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 3270 | 0.030 |
Why?
|
| Feces | 1 | 2020 | 710 | 0.030 |
Why?
|
| Prevalence | 1 | 2003 | 2407 | 0.030 |
Why?
|
| Age Factors | 1 | 2003 | 2801 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2000 | 572 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 1999 | 672 | 0.030 |
Why?
|
| Azacitidine | 1 | 1995 | 54 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1995 | 179 | 0.030 |
Why?
|
| Solubility | 1 | 1995 | 131 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1994 | 58 | 0.030 |
Why?
|
| Europe | 1 | 2015 | 375 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 1995 | 129 | 0.030 |
Why?
|
| Deoxyribonucleoproteins | 1 | 1993 | 3 | 0.030 |
Why?
|
| Macaca mulatta | 3 | 2000 | 494 | 0.030 |
Why?
|
| Protein Sorting Signals | 1 | 1993 | 37 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1993 | 42 | 0.030 |
Why?
|
| Vero Cells | 1 | 1993 | 110 | 0.030 |
Why?
|
| Middle Aged | 2 | 2003 | 26002 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1995 | 571 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 1994 | 175 | 0.030 |
Why?
|
| Biological Transport | 1 | 1993 | 347 | 0.030 |
Why?
|
| Proteins | 1 | 1998 | 1038 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2011 | 237 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1993 | 1081 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2000 | 4493 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2004 | 33 | 0.010 |
Why?
|
| Adolescent | 1 | 2002 | 19118 | 0.010 |
Why?
|
| Epithelium | 1 | 2004 | 366 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 2004 | 269 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2002 | 23 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2002 | 43 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 78 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 666 | 0.010 |
Why?
|
| Carrier State | 1 | 2002 | 76 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 383 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2002 | 177 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2000 | 49 | 0.010 |
Why?
|
| Biopsy | 1 | 2004 | 1239 | 0.010 |
Why?
|
| Monkey Diseases | 1 | 1999 | 18 | 0.010 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 1999 | 68 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2002 | 402 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 462 | 0.010 |
Why?
|
| Tumor Virus Infections | 1 | 1999 | 134 | 0.010 |
Why?
|
| Lymphoma, B-Cell | 1 | 1999 | 135 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 1999 | 809 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 1995 | 14 | 0.010 |
Why?
|
| Methylation | 1 | 1995 | 226 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1994 | 162 | 0.010 |
Why?
|
| Infant | 1 | 2002 | 12347 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2004 | 16022 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2002 | 13889 | 0.000 |
Why?
|
| Child | 1 | 2002 | 24244 | 0.000 |
Why?
|